Vanguard Group
NDRA icon

Vanguard Group’s ENDRA Life Sciences NDRA Stock Holding History

Vanguard Group’s Portfolio NDRA Stock Details NDRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		$58.6K Buy
+12,937
New +$73.8K ﹤0.01% 4222
2024
Q3 		– Sell
-23
Closed -$3.87K – 4368
2024
Q2 		$3.87K Hold
23
– – ﹤0.01% 4408
2024
Q1 		$23.1K Hold
23
– – ﹤0.01% 4381
2023
Q4 		$84.4K Buy
23
+1
+5% +$2.1K ﹤0.01% 4319
2023
Q3 		$43.2K Buy
22
+7
+47% +$15K ﹤0.01% 4424
2023
Q2 		$37.2K Sell
15
-14
-48% -$39.4K ﹤0.01% 4488
2023
Q1 		$114K Hold
29
– – ﹤0.01% 4393
2022
Q4 		$203K Buy
29
+1
+4% +$8.38K ﹤0.01% 4309
2022
Q3 		$305K Sell
28
-5
-15% -$51.6K ﹤0.01% 4342
2022
Q2 		$273K Sell
33
-2
-6% -$17.9K ﹤0.01% 4423
2022
Q1 		$471K Sell
35
-14
-29% -$251K ﹤0.01% 4412
2021
Q4 		$1.18M Hold
49
– – ﹤0.01% 4217
2021
Q3 		$2.96M Hold
49
– – ﹤0.01% 3919
2021
Q2 		$3.73M Buy
49
+4
+9% +$315K ﹤0.01% 3742
2021
Q1 		$4.11M Buy
45
+42
+1,400% +$3.15M ﹤0.01% 3628
2020
Q4 		$73K Hold
3
– – ﹤0.01% 4165
2020
Q3 		$72K Hold
3
– – ﹤0.01% 4044
2020
Q2 		$94K Hold
3
– – ﹤0.01% 3986
2020
Q1 		$71K Hold
3
– – ﹤0.01% 3979
2019
Q4 		$164K Sell
3
-1
-25% -$37.2K ﹤0.01% 3965
2019
Q3 		$137K Sell
4
-2
-33% -$106K ﹤0.01% 3998
2019
Q2 		$359K Sell
6
-1
-14% -$50.5K ﹤0.01% 3879
2019
Q1 		$379K Buy
7
+1
+17% +$73K ﹤0.01% 3823
2018
Q4 		$319K Buy
+6
New +$694K ﹤0.01% 3819

Other funds holding NDRA

ACM
Altium Capital Management New York $42M AUM
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Northwestern Mutual Wealth Management
Northwestern Mutual Wealth Management Milwaukee, Wisconsin $162B AUM 16.35% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Vanguard Group's NDRA Position: Q4 2025 in Review

Vanguard Group opened a new position in ENDRA Life Sciences (NDRA) in Q4 2025: 12,937 shares worth $58.6K. The stake represents ﹤0.01% of the portfolio and ranks #4222 among its holdings. This is a return to the name: Vanguard Group previously reported a position in NDRA as recently as Q2 2024.

Vanguard Group first reported a position in NDRA in Q4 2018 and has held it in 24 quarters since. The position peaked at $4.11M in Q1 2021. 7 funds tracked by Wall St. Rank hold NDRA as of Q4 2025.

  • Vanguard Group held 12,937 shares of ENDRA Life Sciences worth $58.6K as of Q4 2025.
  • ENDRA Life Sciences was a new Vanguard Group position in Q4 2025.
  • ENDRA Life Sciences made up ﹤0.01% of Vanguard Group's portfolio in Q4 2025, its #4222 holding.
  • Vanguard Group first reported a position in ENDRA Life Sciences in Q4 2018 and has held it in 24 quarters since.
  • Vanguard Group's ENDRA Life Sciences position peaked at $4.11M in Q1 2021.
  • 7 funds tracked by Wall St. Rank held ENDRA Life Sciences as of Q4 2025.

Based on Vanguard Group's 13F filing for Q4 2025, filed 29 Jan 2026.